Black Rock Inc. Neuro Pace Inc Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Neuro Pace Inc stock. As of the latest transaction made, Black Rock Inc. holds 74,154 shares of NPCE stock, worth $512,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,154

Previous 86,502 14.27%

Holding current value

$512,404

Previous $891,000 9.76%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$9.78 - $17.5 $120,763 - $216,090	-12,348 Reduced 14.27%	74,154 $978,000
Q4 2023 Feb 13, 2024	BUY	$5.9 - $10.31 $156,550 - $273,565	26,534 Added 44.25%	86,502 $891,000
Q3 2023 Nov 13, 2023	BUY	$4.0 - $9.73 $95,404 - $232,070	23,851 Added 66.04%	59,968 $583,000
Q2 2023 Aug 11, 2023	BUY	$3.98 - $5.12 $14,511 - $18,667	3,646 Added 11.23%	36,117 $162,000
Q1 2023 May 12, 2023	SELL	$1.44 - $5.34 $2,989 - $11,085	-2,076 Reduced 6.01%	32,471 $150,000

Q4 2022 Feb 13, 2023	BUY	$1.29 - $2.98 $11,740 - $27,120	9,101 Added 35.77%	34,547 $51,000
Q3 2022 Nov 14, 2022	BUY	$3.1 - $5.98 $10,416 - $20,092	3,360 Added 15.21%	25,446 $95,000
Q2 2022 Aug 12, 2022	SELL	$4.95 - $8.7 $1.55 Million - $2.72 Million	-313,116 Reduced 93.41%	22,086 $109,000
Q1 2022 May 12, 2022	SELL	$7.06 - $11.57 $34,488 - $56,519	-4,885 Reduced 1.44%	335,202 $2.75 Million
Q4 2021 Feb 10, 2022	BUY	$8.63 - $17.36 $52,755 - $106,121	6,113 Added 1.83%	340,087 $3.43 Million
Q3 2021 Nov 09, 2021	SELL	$15.85 - $25.07 $8,257 - $13,061	-521 Reduced 0.16%	333,974 $5.29 Million
Q2 2021 Aug 11, 2021	BUY	$19.03 - $26.5 $6.37 Million - $8.86 Million	334,495 New	334,495 $7.96 Million

Others Institutions Holding NPCE

# of Institutions

Shares Held

18.7M

Call Options Held

28.9K

Put Options Held

7.5K

View Full List

About NeuroPace Inc

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $172M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

More about NPCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account